English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Worldwide, gastric cancer is a leading cause of mortality (1), with surgery representing the only potentially curative treatment. Despite 5-year survival rates of 40–60% in series from Asia and Europe (2,3). Five-year survival in North America is much worse, approximately 31% (4). Reasons for these survival differences are unclear, but may be related to low-volume surgeons performing resections, less aggressive surgery, poor staging, and differences in biology (5). In addition to resection of the tumor, extent of lymphadenectomy may affect survival. Non-randomized series from Asia and Europe have reported improved survival associated with the more extensive D2 lymphadenectomy (6-10) compared to the more limited D1 lymphadenectomy, Original Article

Evaluating quality and completeness of gastrectomy for gastric cancer: review of surgical videos from the public domain